Laws, Alison
Pastorello, Ricardo
Dey, Tanujit
Grossmith, Samantha
King, Claire
McGrath, Monica
Schnitt, Stuart J.
Mittendorf, Elizabeth A.
King, Tari
Funding for this research was provided by:
Rob and Karen Hale Distinguished Chair in Surgical Oncology
Pam Gelsomini Fellowship Fund
Article History
Received: 12 January 2022
Accepted: 7 June 2022
First Online: 9 July 2022
Declarations
:
: T.A.K. reports speakers honoraria and advisory board participation for Exact Sciences (formerly Genomic Health) and global advisory board participation for Besins Healthcare. E.A.M. reports clinical trial funding from Roche/Genentech (via SU2C grant) and Gilead; compensated advisory board service for, and consulting fees from, Roche/Genentech, Merck, and Exact Sciences; compensated advisory board service for AstraZeneca; honoraria from Physicians’ Education Resource; and uncompensated service on the Board of Directors for the American Society of Clinical Oncology, the steering committees of Roche/Genentech, Bristol-Myers Squibb, and Eli Lilly, and uncompensated service as a Scientific Advisor for Susan G. Komen for the Cure Foundation.